All timeline stories.

16/06/2021

CRISPR-Cas genome editing technology

Nominated by: Spanish Bioindustry Association – AseBio, Lithianian Biotechnology Association   People in nomination: Professor Francisco Martinez Mojica, Department of Physiology, Genetics and Microbiology, University of..Read More
16/06/2021

2003: Targeting regulation of protein production for new medicines

Nominated by: PTC Therapeutics Organisation in nomination: PTC Therapeutics Diseases associated with protein disorders, such as Duchenne muscular dystrophy and spinal muscular atrophy have long been..Read More
16/06/2021

It’s coming…

16/06/2021

2005: Europe’s largest medicines biotechnology facilities open: Pfizer Grange Castle, Dublin

Nominated by: Pfizer  Organisations in nomination: Pfizer The Pfizer Grange Castle Biotechnology facility commenced construction in 2000 and was licensed and officially opened in 2005.  It..Read More
16/06/2021

2007: Trabectedin (ET-743, Yondelis®) first anti-cancer drug from marine origins approved in Europe

Nominated by: Spanish Bioindustry Association – AseBio  Organisation in nomination: Pharmamar (Spain)              Marine environments are considered more biologically diverse than..Read More
16/06/2021

It’s coming…

16/06/2021

It’s coming…

16/06/2021

It’s coming…

16/06/2021

2018: First CAR T cell therapy approved in the US for adult patients with DLBCL and amongst the first approved in Europe

Nominated by: Kite (a Gilead Company)    Organisations in nomination: Kite (a Gilead Company) Non-Hodgkin lymphoma (NHL) can occur at any age, and accounts for an..Read More
16/06/2021

2012: Collaborative patient partnership delivers first treatment approved in Europe for genetic disease, Alkaptonuria (AKU)

Nominated by: Sobi, Swedish Orphan Biovitrum  Organisations in nomination: DevelopAKUre Consortium AKU is a serious, multi-system disorder affecting approximately 1 in 250,000 people, first described as..Read More
16/06/2021

2013: First approved cancer treatment using antibody glycosylation (glycoMAb) – Gazyvaro

Nominated by: Swiss Biotech Association  Organisations in nomination: Glycart Biotechnology (now Roche Glycart AG) Pioneer in antibody glycosylation (glycoMAb) technology increasing immune-mediated killing of cancer cells..Read More
16/06/2021

2000: Provitamin A enriched “Golden Rice” to combat vitamin A deficiency and blindness

Nominated by: Scienceindustries Switzerland  Organisation in nomination: Swiss Federal Institute of Technology, University of Freiburg    In 2000, the research teams of Ingo Potrykus (Swiss Federal..Read More
08/06/2021

2020: First large scale application of AI to protein structure determination: AlfaFold

Nominated by: UK BioIndustry Association  Organisation in nomination: DeepMind   An artificial intelligence (AI) network developed by Google AI offshoot DeepMind made a gargantuan leap in solving..Read More
09/05/2021

2018: Autologous CAR-T cell therapy Kymriah – unique to each patient. First EC approval for two indications (pALL and DLBCL)

Nominated by: Novartis Organisations in nomination: Novartis Acute lymphoblastic leukaemia (ALL) is a type of cancer that affects white blood cells. It progresses quickly and aggressively..Read More
09/05/2021

2018: European “1+ Million Genomes” Initiative launched

Nominated by: Voisin Consulting Life Sciences The European “1+ Million Genomes” Initiative builds from the achievements of the Human Genome Project and aims to have at..Read More
09/05/2021

2020: First vaccine for the prevention of COVID-19 to receive conditional marketing authorization from the European Medicines Agency: COMIRNATY® (BNT162b2/Pfizer-BioNTech COVID-19 vaccine)

Nominated by: Pfizer Organisations in nomination: Pfizer, BioNTech     In March 2020, the WHO declared COVID-19 a pandemic. At “lightspeed,” Pfizer collaborated with BioNTech, a..Read More
07/05/2021

2016: World’s first industrial scale plant for production of butanediol (1,4 BDO) from renewable materials via biosynthesis (fermentation from micro-organisms)

Nominated by: Federchimica Assobiotec  Organisation in nomination: Novamont (Italy) 1,4, Butanediol is a chemical intermediate used for a wide range of applications, including industrial processes (as..Read More
Become a member